[1] Zhou MG, Wang HD, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet, 2016; 387, 251-72. doi:  10.1016/S0140-6736(15)00551-6
[2] Zhai FY, Du SF, Wang ZH, et al. Dynamics of the Chinese diet and the role of urbanicity, 1991-2011. Obesity Reviews, 2014; 15, 16-26. doi:  10.1111/obr.2014.15.issue-s1
[3] Ng SW, Norton EC, Popkin BM. Why have physical activity levels declined among Chinese adults? Findings from the 1991-2006 China Health and Nutrition Surveys. Soc Sci Med, 2009; 68, 1305-14. doi:  10.1016/j.socscimed.2009.01.035
[4] Mi YJ, Zhang B, Wang HJ, et al. Prevalence and secular trends in obesity among Chinese adults, 1991-2011. Am J Prev Med, 2015; 49, 661-9. doi:  10.1016/j.amepre.2015.05.005
[5] Li JH, Wang LM, Li YC, et al. Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Disease in Women in China: Surveillance Efforts. , Zhang M, Wang LH. Biomed Environ Sci, 2016; 29, 205-11.
[6] Wu YF, Huxley R, Li LM, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation, 2008; 118, 2679-86. doi:  10.1161/CIRCULATIONAHA.108.788166
[7] Li YC, Yang L, Wang LM, et al. Burden of Hypertension in China: A nationally representative survey of 174, 621 adults. Int J Cardiol, 2017; 227, 516-23. doi:  10.1016/j.ijcard.2016.10.110
[8] Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 1997; 20, 1664-9. doi:  10.2337/diacare.20.11.1664
[9] Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA, 2013; 310, 948-59. doi:  10.1001/jama.2013.168118
[10] He J, Gu DF, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004; 110, 405-11. doi:  10.1161/01.CIR.0000136583.52681.0D
[11] Yang ZJ, Liu J, Ge JP, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J, 2012; 33, 213-20. doi:  10.1093/eurheartj/ehr205
[12] Liu SW, Zhang M, Yang L, et al. Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey. J Epidemiol Community Health, 2017; 71, 154-61. doi:  10.1136/jech-2016-207805
[13] Du SF, Neiman A, Batis C, et al. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr, 2014; 99, 334-43. doi:  10.3945/ajcn.113.059121
[14] Moran A, Gu DF, Zhao D, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes, 2010; 3, 243-52. doi:  10.1161/CIRCOUTCOMES.109.910711
[15] Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97, 1837-47. doi:  10.1161/01.CIR.97.18.1837
[16] Liu J, Hong YL, D'Agostino RB, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA, 2004; 291, 2591-9. doi:  10.1001/jama.291.21.2591
[17] Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation, 2006; 114, 2217-25. doi:  10.1161/CIRCULATIONAHA.105.607499
[18] Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guildlines. J Am Coll Cardiol, 2014; 63, 2935-59. doi:  10.1016/j.jacc.2013.11.005
[19] Rana JS, Tabada GH, Solomon MD, et al. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large contemporary, multiethnic population. J Am Coll Cardiol, 2016; 67, 2118-30. http://paper.medlive.cn/literature/1869133
[20] Liu SW, Wu X, Lopez AD, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ, 2016; 94, 46-57. doi:  10.2471/BLT.15.153148
[21] World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
[22] Armstrong T, Bull F. Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health (Oxf), 2006; 14, 66-70. doi:  10.1007/s10389-006-0024-x
[23] Chinese Guidelines for Prevention of Cardiovascular Disease. Chin J Cardiol, 2011; 39, 3-22. (In Chinese)
[24] Hu N, Jiang Y, Li YC, et al. Data weighting methods for China chronic disease surveillance (2010). Chinese Journal of Health Statistics, 2012; 29, 424-26. (In Chinese)
[25] Zhang M, Huang ZJ, Li YC, et al. Prediction of 10-year risk for ischemic cardiovascular disease in adults aged ≥ 35 years in China. Chin J Epidemiol, 2016; 37, 695-9. (In Chinese)
[26] Wu LX, Zen Q, Qiang DC. The distribution of 10-year cardiovascular risk in Chinese adults: analysis of the China Health Examination Database (CHED) 2008. J Geriatr Cardiol, 2010; 7, 3-4. http://www.oalib.com/paper/1688113
[27] Ford ES, Giles WH, Mokdad AH. The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey Ⅲ. J Am Coll Cardiol, 2004; 43, 1791-6. doi:  10.1016/j.jacc.2003.11.061
[28] Lee K. 10-year risk for atherosclerotic cardiovascular disease and coronary heart disease among Korean adults: findings from the Korean National Health and Nutrition Examination Survey 2009-2010. Int J Cardiol, 2014; 176, 418-22. doi:  10.1016/j.ijcard.2014.07.101
[29] Kavousi M, Leening MJ, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel Ⅲ guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA, 2014; 311, 1416-23. doi:  10.1001/jama.2014.2632
[30] Oscar H, Chris DL, Anna P, et al. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med, 2005; 165, 2355-60. doi:  10.1001/archinte.165.20.2355
[31] Chen AH, Tseng CH. The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review. Rev Diabet Stud, 2013; 10, 101-9. doi:  10.1900/RDS.2013.10.101
[32] Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J, 2015; 14, 6. doi:  10.1186/1475-2891-14-6
[33] hang Y, Wang SG, Ma YX, et al. Association between ambient air pollution and hospital emergency admissions for respiratory and cardiovascular diseases in Beijing: a time series study. Biomed Environ Sci. 2015; 28, 352-63.
[34] Tian YF, Zhou YP, Zhong CK, et al. C-reactive protein Level, apolipoprotein B-to-apolipoprotein A-1 ratio, and risks of ischemic stroke and coronary heart disease among inner Mongolians in China. Biomed Environ Sci, 2016; 29, 467-74.
[35] Feng YJ, Wang HC, Li YC, et al. Hypertension screening and follow-up management by primary health care system among Chinese population aged 35 years and above. Biomed Environ Sci, 2015; 28, 330-40. https://www.researchgate.net/publication/278047071_Hypertension_Screening_and_Follow-up_Management_by_Primary_Health_Care_System_among_Chinese_Population_Aged_35_Years_and_Above
[36] Setayeshgar S, Whiting SJ, Vatanparast H. Prevalence of 10-year risk of cardiovascular diseases and associated risks in Canadian adults: the contribution of cardio-metabolic risk assessment introduction. Int J Hypertens, 2013; 2013, 276564.